Controlling oxygen release from hollow microparticles for prolonged cell survival under hypoxic environment
Source abstract
Abstract
The survival of cells in the 3D scaffold until the ingrowth of blood vessels is one of the most important challenges in tissue engineering for producing a clinically relevant volume of tissue. In this study, perfluorooctane emulsion (oxygen carrier)-loaded hollow microparticles (PFO-HPs) were prepared as a scaffolding system which can allow timely release of oxygen to cells adhered on the HPs to prevent cell necrosis in a hypoxic environment (inherently created in tissue engineered 3D constructs) until new blood vessels are formed in the 3D cell construct, and thus may produce appropriate tissues/organs with a clinically relevant volume. In the in vitro cell culture and the in vivo animal study, it was observed that the cells initially seeded on the PFO-HPs remained alive for approximately 10 days in a hypoxic environment (in vitro), and the cells were also found throughout the implanted whole matrix without a necrotic center until the infiltration of blood vessels (at 14 days after implantation; in vivo), probably due to the sufficient release of oxygen from the PFO-HPs for an adequate time period. Based on these results, the cell-based PFO-HPs can be a promising system to produce a clinically applicable large tissue mass.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Downregulation of metabolic activity increases cell survival under hypoxic conditions: potential applications for tissue engineering10.1089/ten.tea.2013.0637 ↗
2. Regenerative medicine and organ transplant: past, present, and future10.1097/TP.0b013e318219ebb5 ↗
3. Toward development of an implantable tissue engineered liver10.1016/0142-9612(96)85575-X ↗
4. Tissue engineering strategies for in vivo neovascularisation10.1517/14712598.2.8.805 ↗
5. Microscale technologies for tissue engineering and biology10.1073/pnas.0507681102 ↗
6. Angiogenesis in cancer and other diseases10.1038/35025220 ↗
7. Uniform tissues engineered by seeding and culturing cells in 3D scaffolds under perfusion at defined oxygen tensions
8. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons10.1002/bit.21151 ↗
9. The effect of perfluorocarbon-based artificial oxygen carriers on tissue-engineered trachea10.1089/ten.tea.2008.0461 ↗
10. Tissue engineering scaffolds containing embedded fluorinated-zeolite oxygen vectors10.1016/j.actbio.2011.06.010 ↗
11. Locally enhanced angiogenesis promoters transplanted cell survival10.1089/107632704322791709 ↗
12. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor10.1002/jbm.a.30843 ↗
13. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF10.1016/j.biomaterials.2006.10.029 ↗
14. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterals10.1016/j.biomaterials.2006.06.015 ↗
15. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach10.1073/pnas.0800069105 ↗
16. Perfluorocarbon-based oxygen carriers: review of products and trials10.1111/j.1525-1594.2009.00944.x ↗
17. Diffusion limits of an in vitro thick prevascularized tissue10.1089/ten.2005.11.257 ↗
18. An oxygen release system to augment cardiac progenitor cell survival and differentiation under hypoxic condition10.1016/j.biomaterials.2012.05.012 ↗
19. Controlled release of oxygen from PLGA-alginate layered matrix and its in vitro characterization on the viability of muscle cells under hypoxic environment10.1007/s13770-013-0391-7 ↗
20. Oxygen producing biomaterials for tissue regeneration10.1016/j.biomaterials.2007.07.003 ↗
21. Oxygen generating biomaterials preserve skeletal muscle homeostasis under hypoxic and ischemic conditions10.1371/journal.pone.0072485 ↗
22. Oxygen generating scaffolds for enhancing engineered tissue survival10.1016/j.biomaterials.2008.09.065 ↗
23. Oxygen-generating nanofiber cell scaffolds with antimicrobial properties10.1021/am100862h ↗
24. Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials10.1073/pnas.1113560109 ↗
25. Controlled oxygen release from pyridone endoperoxides promotes cell survival under anoxic conditions10.1021/jm4016137 ↗
26. Oxygen-generating scaffolds: a new strategy for bone tissue engineering10.1016/j.bone.2013.07.034 ↗
27. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres10.1016/S0168-3659(00)00299-6 ↗
28. Expression of hypoxia-inducible factor 1: mechanisms and consequences10.1016/S0006-2952(99)00292-0 ↗
29. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 110.1128/MCB.16.9.4604 ↗
30. Novel fabrication of PCL porous beads for use as an injectable cell carrier system10.1002/jbm.b.31313 ↗
31. A new technique to efficiency entrap leuprolide acetate into microcapsules of poly(lactic acid) or copoly(lactic/glycolic acid)10.1248/cpb.36.1095 ↗
32. Biodegradable somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods10.1016/S0939-6411(97)00125-2 ↗
33. Bioresorbable microspheres by spinning disk atomization as injectable cell carrier: from preparation to in vitro evaluation10.1016/S0142-9612(99)00276-8 ↗
34. Fabrication of polystyrene hollow microspheres as laser fusion targets by optimized density-matched emulsion technique and characterization10.1007/s12043-002-0036-1 ↗
35. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres10.1016/S0168-3659(97)01647-7 ↗
36. Nile red fluorescence demonstrates lipid in the envelope of vesicles from N2-fixing cultures of Frankia10.1139/m88-108 ↗
37. Perfluorochemicals: their applications and benefits to cell culture10.1016/S0167-7799(98)01205-0 ↗
38. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery10.1081/BIO-200046659 ↗
39. Inhibition of tumor angiogenesis mediated by cartilage10.1084/jem.141.2.427 ↗
40. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis10.1038/28867 ↗